Fatigue in Systemic Lupus Erythematosus and Rheumatoid Arthritis

PM and R

Volumn 2, Issue 5, 2010, Pages 384-392

  Ramsey Goldman, Rosalind ^a   Rothrock, Nan ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BELIMUMAB; ETANERCEPT; INTERLEUKIN 1; INTERLEUKIN 6; METHOTREXATE; PLACEBO; PRASTERONE; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA;

ACUPUNCTURE; ANXIETY DISORDER; ARTICLE; CAUSAL ATTRIBUTION; CLINICAL ASSESSMENT; DAYTIME SOMNOLENCE; DEPRESSION; DISEASE SEVERITY; EXERCISE TOLERANCE; FATIGUE; HUMAN; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; RELIABILITY; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SLEEP DISORDER; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT INDICATION; TREATMENT RESPONSE; VALIDITY;

ARTHRITIS, RHEUMATOID; COGNITION DISORDERS; FATIGUE; HEALTH STATUS INDICATORS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 77952822205     PISSN: 19341482     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmrj.2010.03.026     Document Type: Article

References (110)

1. Rahman A., and Isenberg D.A. Systemic lupus erythematosus. N Engl J Med 358 (2008) 929-939
2. Gordon C., and Ramsey-Goldman R. Systemic lupus eruthematosus and lupus-like syndromes. In: Adebajo A. (Ed). ABC of Rheumatology. 4th ed. (2009), Wiley-Blackwell, Chichester, UK
3. Tan E.M., Cohen A.S., Fries J.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25 (1982) 1271-1277
4. Hochberg M.C. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40 (1997) 1725
5. Krupp L.B., LaRocca N.G., Muir J., and Steinberg A.D. A study of fatigue in systemic lupus erythematosus. J Rheumatol 17 11 (1990) 1450-1452
6. Tench C.M., McCurdie I., White P.D., and D'Cruz D.P. The prevalence and associations of fatigue in systemic lupus erythematosus. Rheumatology (Oxford) 39 (2000) 1249-1254
7. Zonana-Nacach A., Roseman J.M., McGwin Jr. G., Friedman A.W., Baethge B.A., and Reveille J.D. Systemic lupus erythematosus in three ethnic groups. VI: Factors associated with fatigue within 5 years of criteria diagnosis. Lupus 9 (2000) 101-109
8. Burgos P.I., Alarcon G.S., McGwin Jr. G., Crews K.Q., Reveille J.D., and Vila L.M. Disease activity and damage are not associated with increased levels of fatigue in systemic lupus erythematosus patients from a multiethnic cohort: LXVII. Arthritis Rheum 61 (2009) 1179-1186
9. National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases. The Future Directions of Lupus Research. 2007. http://www.niams.nih.gov/About_Us/Mission_and_Purpose/lupus_plan.pdf Accessed December 17, 2009
10. Al Dhanhani A.M., Gignac M.A., Su J., and Fortin P.R. Work disability in systemic lupus erythematosus. Arthritis Rheum 61 (2009) 378-385
11. Panopalis P., Yazdany J., Gillis J.Z., et al. Health care costs and costs associated with changes in work productivity among persons with systemic lupus erythematosus. Arthritis Care Res 59 (2008) 1788-1795
12. Krupp L.B., LaRocca N.G., Muir-Nash J., and Steinberg A.D. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46 (1989) 1121-1123
13. Robb-Nicholson L.C., Daltroy L., Eaton H., et al. Effects of aerobic conditioning in lupus fatigue: a pilot study. Rheumatology 28 (1989) 500-505
14. Chalder T., Berelowitz G., Pawlikowska T., et al. Development of a fatigue scale. J Psychosom Res 37 (1993) 147-153
15. Schwartz J.E., Jandorg L., and Krupp L.B. The measurement of fatigue: A new instrument. J Psychosom Res 17 (1993) 762
16. Taylor J., Skan J., Erb N., et al. Lupus patients with fatigue-is there a link with fibromyalgia syndrome?. Rheumatology 39 (2000) 620-623
17. Stoll T., Gordon C., Seifert B., et al. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36: Its association with disease activity and damage in patients with systemic lupus erythematosus. J Rheumatol 24 (1997) 1608-1614
18. Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria for Fatigue. Measurement of fatigue in systemic lupus erythematosus: A systematic review. Arthritis Care Res 57 (2007) 1348-1357
19. Goligher E.C., Pouchot J., Brant R., et al. Minimal clinically important difference for 7 measures of fatigue in patients with systemic lupus erythematosus. J Rheumatol 35 (2008) 635-642
20. Lai JS, Cella D, Choi S, Teresi JA, Hays RD, Stone AA. Developing a fatigue item bank for the Patient-Reported Outcomes Measurement Information System (PROMIS FIB version 1). Presented at the Meeting of the Survey Methods in Multicultural, Multinational, and Multiregional Contexts (3MC), Berlin, Germany; 2008.
21. Lai JS, Beaumont JL, Cella D, Brunetta P, Ogale S. Validation of the Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue Scale in patients with systemic lupus erythematosus (SLE). Paper presented at: ISPOR 12th Annual European Congress; 2009; Paris, France.
22. Cella D., Yount S., Rothrock N., et al. The Patient-Reported Outcomes Measurement Information System (PROMIS): Progress of an NIH Roadmap Cooperative Group During its First Two Years. Med Care 45 5 Suppl 1 (2007) S3-S11
23. Harboe E., Greve O.J., Beyer M., et al. Fatigue is associated with cerebral white matter hyperintensities in patients with systemic lupus erythematosus. J Neurol Neurosurg Psychiatry 79 (2008) 199-201
24. Omdal R., Mellgren S.I., Koldingsnes W., Jacobsen E.A., and Husby G. Fatigue in patients with systemic lupus erythematosus: Lack of associations to serum cytokines, antiphospholipid antibodies, or other disease characteristics. J Rheumatol 29 (2002) 482-486
25. Omdal R., Sjöholm H., Koldingsnes W., et al. Fatigue in patients with lupus is not associated with disturbances in cerebral blood flow as detected by SPECT. J Neurol 252 (2005) 78-83
26. Ramsey-Goldman R., Schilling E.M., Dunlop D., et al. A pilot study on the effects of exercise in patients with systemic lupus erythematosus. Arthritis Care Res 13 (2000) 262-269
27. Carvalho M.R., Sato E.I., Tebexreni A.S., Heidecher R.T., Schenkman S., and Neto T.L. Effects of supervised cardiovascular training program on exercise tolerance, aerobic capacity, and quality of life in patients with systemic lupus erythematosus. Arthritis Rheum 53 (2005) 838-844
28. Tench C., Bentley D., Vleck V., McCurdie I., White P., and D'Cruz D. Aerobic fitness, fatigue, and physical disability in systemic lupus erythematosus. J Rheumatol 29 (2002) 474-481
29. Campillo B., Fouet P., Bonnet J.C., and Atlan G. Submaximal oxygen consumption in liver cirrhosis. Evidence of severe functional aerobic impairment. J Hepatol 10 (1990) 163-167
30. Zdrenghea D., Giurgea N., Predescu D., Timis D., and Icusca G. Exercise testing in patients with valvular diseases. Rom J Intern Med 32 (1994) 23-28
31. Keyser R.E., Rus V., Cade W.T., Kalappa N., Flores R.H., and Handwerger B.S. Evidence for aerobic insufficiency in women with systemic lupus erythematosus. Arthritis Care Res 49 (2003) 16-22
32. Bostrom C., Dupre B., Tengvar P., Jansson E., Opava C., and Lundberg I. Aerobic capacity correlates to self-assessed physical function but not to overall disease activity or organ damage in women with systemic lupus erythematosus with low-to-moderate disease activity and organ damage. Lupus 17 (2008) 100-104
33. Costa D.D., Bernatsky S., Dritsa M., et al. Determinants of sleep quality in women with systemic lupus erythematosus. Arthritis Rheum 53 (2005) 272-278
34. McKinley P.S., Ouellette S.C., and Winkel G.H. The contributions of disease activity, sleep patterns, and depression to fatigue in systemic lupus erythematosus. Arthritis Rheum 38 (1995) 826-834
35. Valencia-Flores M., Resendiz M., Castãno V.A., et al. Objective and subjective sleep disturbances in patients with systemic lupus erythematosus. Arthritis Rheum 42 (1999) 2189-2193
36. Gudbjornsson B., and Hetta J. Sleep disturbances in patients with systemic lupus erythematosus: a questionnaire-based study. Clin Exp Rheumatol 19 (2001) 509-514
37. Greenwood K.M., Lederman L., and Lindner H.D. Self-reported sleep in systemic lupus erythematosus. Clin Rheumatol 27 (2008) 1147-1151
38. Iaboni A., Ibanez D., Gladman D.D., Urowitz M.B., and Moldofsky H. Fatigue in systemic lupus erythematosus: contributions of disordered sleep, sleepiness, and depression. J Rheumatol 33 (2006) 2453-2457
39. Ranjbaran Z., Keefer L., Stepanski E., Farhadi A., and Keshavarzian A. The relevance of sleep abnormalities to chronic inflammatory conditions. Inflamm Res 56 (2007) 51-57
40. Brey R.L., Holliday S.L., Saklad A.R., et al. Neuropsychiatric syndromes in lupus: Prevalence using standardized definitions. Neurology 58 (2002) 1214-1220
41. Ayan C., and Martin V. Systemic lupus erythematosus and exercise. Lupus 16 (2007) 5-9
42. Daltroy L.H., Robb-Nicholson C., Iversen M.D., Wright E.A., and Liang M.H. Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. Br J Rheumatol 34 (1995) 1064-1069
43. Tench C.M., McCarthy J., McCurdie I., White P.D., and D'Cruz D.P. Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. Rheumatology 42 (2003) 1050-1054
44. Jump R.L., Robinson M.E., Armstrong A.E., Barnes E.V., Kilbourn K.M., and Richards H.B. Fatigue in systemic lupus erythematosus: contributions of disease activity, pain, depression, and perceived social support. J Rheumatol 32 (2005) 1699-1705
45. Wang B., Gladman D.D., and Urowitz M.B. Fatigue in lupus is not correlated with disease activity. J Rheumatol Suppl 25 (1998) 892-894
46. Da Costa D., Dritsa M., Bernatsky S., et al. Dimensions of fatigue in systemic lupus erythematosus: Relationship to disease status and behavioral and psychosocial factors. J Rheumatol 33 (2006) 1282-1288
47. Fortin P.R., Abrahamowicz M., Neville C., et al. Impact of disease activity and cumulative damage on the health of lupus patients. Lupus 7 (1998) 101-107
48. Wang C., Mayo N.E., and Fortin P.R. The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosus. J Rheumatol 28 (2001) 525-532
49. Aaronson L.S., Teel C.S., Cassmeyer V., et al. Defining and measuring fatigue. Image J Nurs Sch 31 (1999) 45-50
50. Kozora E., West S.G., Kotzin B.L., Julian L., Porter S., and Bigler E. Magnetic resonance imaging abnormalities and cognitive deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum 41 (1998) 41-47
51. Denburg S.D., Carbotte R.M., Ginsberg J.S., and Denburg J.A. The relationship of antiphospholipid antibodies to cognitive function in patients with systemic lupus erythematosus. J Int Neuropsychol Soc 3 (1997) 377-386
52. Denburg S.D., Carbotte R.M., and Denburg J.A. Cognitive impairment in systemic lupus erythematosus: A neuropsychological study of individual and group deficits. J Clin Exp Neuropsychol 9 (1987) 323-339
53. Mikdashi J.A. Proposed response criteria for neurocognitive impairment in systemic lupus erythematosus clinical trials. Lupus 16 (2007) 418-425
54. Marsland A.L., Petersen K.L., Sathanoori R., et al. Interleukin-6 covaries inversely with cognitive performance among middle-aged community volunteers. Psychosom Med 68 (2006) 895-903
55. Bernatsky S., Boivin J.F., Joseph L., et al. Mortality in systemic lupus erythematosus. Arthritis Rheum 54 (2006) 2550-2557
56. Omdal R., Waterloo K., Koldingsnes W., Husby G., and Mellgren S.I. Fatigue in patients with systemic lupus erythematosus: The psychosocial aspects. J Rheumatol 30 (2003) 283-287
57. Greco C., Kao A., Maksimowicz-McKinnon K., et al. Acupuncture for systemic lupus erythematosus: A pilot RCT feasibility and safety study. Lupus 17 (2008) 1108-1116
58. Meenan R.F., Gertman P.M., and Mason J.H. Measuring health status in arthritis: The Arthritis Impact Measurment Scales. Arthritis Rheum 23 (1980) 142-152
59. Meenan R.F., Mason J.H., Anderson J.J., Guccione A.A., and Kazis L.E. AIMS2. The content and properties of a revised and expanded Arthritis Impact Measurement Scales Health Status Questionnaire. Arthritis Rheum 35 (1992) 1-10
60. Ware Jr. J.E., and Sherbourne C.D. The MOS 36-item Short-Form Health Survey (SF-36). I. Conceptual Framework and Item Selection. Med Care 30 (1992) 473-483
61. Karlson E.W., Liang M.H., Eaton A., Huang J., Fitzgerald L., Rogers M.D., and Daltroy L.H. A randomized clinical trial of psychoeducational intervention to improve outcomes in systemic lupus erythematosus. Arthritis Rheum 50 (2004) 1832-1841
62. Goodenow C., Reisine S.T., and Grady K.E. Quality of social support and associated social and psychological functioning in women with rheumatoid arthritis. Health Psychol 9 (1990) 266-284
63. Karlson E.W., Daltroy L.H., Rivest C., et al. Validation of a systemic lupus activity questionnaire (SLAQ) for population studies. Lupus 12 (2003) 280-286
64. Hartkamp A., Geenen R., Godaert G.L.R., Bijl M., Bijlsma J.W.J., and Derksen R.H.W.M. Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus. A randomized controlled trial. Ann Rheum Dis (2010) In press
65. Smets E.M.A., Garssen B., Bonke B., and DeHaes J.C.J.M. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 39 (1995) 315-325
66. Cella D., Yount S., Sorensen M., Chartash E., Sengupta N., and Grober J. Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol 32 (2005) 811-819
67. Navarra S., Guzman R., Gallacher A., et al. Belimumab, a BLyS-specific inhibitor, reduced disease activity, flares and prednisone use in patients with active SLE: Efficacy and safety results from the Phase 3 BLISS-52 Study. Arthritis Rheum 60 October 2009 Abstract Suppl (2009) 3860
68. Banal F., Dougados M., Combescure C., and Gossec L. Sensitivity and specificity of the American College of Rheumatology 1987 criteria for the diagnosis of rheumatoid arthritis according to disease duration: A systematic literature review and meta-analysis. Ann Rheum Dis 68 (2009) 1184-1191
69. Lawrence R.C., Helmich C.G., Arnett F.C., et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 41 (1998) 778-799
70. Arnett F.C., Edworthy S.M., Bloch D.A., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31 (1988) 315-324
71. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 Update. Arthritis Rheum 46 (2002) 328-346
72. Wolfe F., and Hawley D.J. Measurement of the quality of life in rheumatic disorders using the EuroQol. Br J Rheumatol 36 (1997) 786-793
73. Listing J., Strangfeld A., Rau R., et al. Clinical and functional remission: even though biologics are superior to conventional DMARDs overall success rates remain low-results from RABBIT, the German biologics register. Arthritis Res Ther 8 (2006) R66
74. Lillegraven S., and Kvien T.K. Measuring disability and quality of life in established rheumatoid arthritis. Best Pract Res Clin Rheumatol 21 (2007) 827-840
75. Hewlett S., Hehir M., and Kirwan J.R. Measuring fatigue in rheumatoid arthritis: A systematic review of scales in use. Arthritis Care Res 57 (2007) 429-439
76. Pouchot J., Kherani R.B., Brant R., et al. Determination of the minimal clinically important difference for seven fatigue measures in rheumatoid arthritis. J Clin Epidemiol 61 (2008) 705-713
77. Repping-Wuts H., Hewlett S., Riel P.V., and Achterberg T.V. Fatigue in patients with rheumatoid arthritis: British and Dutch nurses' knowledge, attitudes and management. J Adv Nurs 65 (2009) 901-911
78. Wolfe F., Hawley D.J., and Wilson K. The prevalence and meaning of fatigue in rheumatic disease. J Rheumatol 23 (1996) 1407-1417
79. Pollard L.C., Choy E.H., Gonzalez J., Khoshaba B., and Scott D.L. Fatigue in rheumatoid arthritis reflects pain, not disease activity. Rheumatology 45 (2006) 885-889
80. Belza B.L., Henke C.J., Yelin E.H., Epstein W.V., and Gilliss C.L. Correlates of fatigue in older adults with rheumatoid arthritis. Nurs Res 42 (1993) 93-99
81. Pinals R.S., Masi A.T., and Larsen R.A. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 24 (1981) 1308-1315
82. Kosinski M., Kujawski S.C., Martin R., et al. Health-related quality of life in early rheumatoid arthritis: Impact of disease and treatment response. Am J Manag Care 8 (2002) 231-240
83. Yount S., Sorensen M.V., Cella D., Sengupta N., Grober J., and Chartash E.K. Adalimumab plus methotrexate or standard therapy is more effective than methotrexate or standard therapies alone in the treatment of fatigue in patients with active, inadequately treated rheumatoid arthritis. Clin Exp Rheumatol 25 (2007) 838-846
84. Hewlett S., Cockshott Z., Byron M., et al. Patients' perceptions of fatigue in rheumatoid arthritis: Overwhelming, uncontrollable, ignored. Arthritis Care Res 53 (2005) 697-702
85. Stone A.A., Broderick J.E., Porter L.S., and Kaell A.T. The experience of rheumatoid arthritis pain and fatigue: examining momentary reports and correlates over one week. Arthritis Care Res 10 (1997) 185-193
86. Mancuso C.A., Rincon M., Sayles W., and Paget S.A. Psychosocial variables and fatigue: A longitudinal study comparing individuals with rheumatoid arthritis and healthy controls. J Rheumatol 33 (2006) 1496-1502
87. Hewlett S.A. Patients and clinicians have different perspectives on outcomes in arthritis. J Rheumatol 30 (2003) 877-879
88. Repping-Wuts H., van Riel P., and van Achterberg T. Rheumatologists' knowledge, attitude and current management of fatigue in patients with rheumatoid arthritis (RA). Clin Rheumatol 27 (2008) 1549-1555
89. Wolfe F., and Michaud K. Fatigue, rheumatoid arthritis, and anti-tumor necrosis factor therapy: an investigation in 24,831 patients. J Rheumatol 31 (2004) 2115-2120
90. Kirwan J.R., and Hewlett S. Patient perspective: Reasons and methods for measuring fatigue in rheumatoid arthritis. J Rheumatol 34 (2007) 1171-1173
91. Kirwan J.R., Minnock P., Adebajo A., et al. Patient perspective: Fatigue as a recommended patient centered outcome measure in rheumatoid arthritis. J Rheumatol 34 (2007) 1174-1177
92. Heller J.E., and Shadick N.A. Outcomes in rheumatoid arthritis: Incorporating the patient perspective. Curr Opin Rheumatol 19 (2007) 101-105
93. Methiniti D., Coulson E., and Kelly C. Fatigue in rheumatoid arthritis. Rheumatology 48 (2009) 1166-1180
94. Wilson A., Yu H.-T., Goodnough L.T., and Nissenson A.R. Prevalence and outcomes of anemia in rheumatoid arthritis: A systematic review of the literature. Am J Med 116 Suppl 1 (2004) 50-57
95. Bergman M.J., Shahouri S.S., Shaver T.S., et al. Is fatigue an inflammatory variable in rheumatoid arthritis (RA)?. Analyses of fatigue in RA, osteoarthritis, and fibromyalgia. J Rheumatol 36 (2009) 2788-2794
96. Capellino S., and Straub R.H. Neuroendocrine immune pathways in chronic arthritis. Best Pract Res Clin Rheumatol 22 (2008) 285-297
97. Repping-Wuts H., van Riel P., and van Achterberg T. Fatigue in patients with rheumatoid arthritis: What is known and what is needed. Rheumatology 48 (2009) 207-209
98. Huyser B.A., Parker J.C., Thoreson R., Smarr K.L., Johnson J.C., and Hoffman R. Predictors of subjective fatigue among individuals with rheumatoid arthritis. Arthritis Rheum 41 (1998) 2230-2237
99. Fifield J., McQuillan J., Tennen H., et al. History of affective disorder and the temporal trajectory of fatigue in rheumatoid arthritis. Ann Behav Med 23 (2001) 34-41
100. Kalyoncu U., Dougados M., Daures J.-P., and Gossec L. Reporting of patient-reported outcomes in recent trials in rheumatoid arthritis: A systematic literature review. Ann Rheum Dis 68 (2009) 183-190
101. Mäkinen H., Hannonen P., and Sokka T. Definitions of remission for rheumatoid arthritis and review of selected clinical cohorts and randomised clinical trials for the rate of remission. Clin Exp Rheumatol 24 Suppl 43 (2006) S22-S28
102. Saag K.G., Teng G.G., Patkar N.M., et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 59 (2008) 762-784
103. Russell A.S. Quality-of-life assessment in rheumatoid arthritis. Pharmacoeconomics 26 (2008) 831-846
104. Strand V., Scott D.L., Emery P., et al. Physical function and health related quality of life: analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritis. J Rheumatol 32 (2005) 590-601
105. Strand V., and Singh J.A. Improved health-related quality of life with effective disease-modifying antirheumatic drugs: Evidence from randomized controlled trials. Am J Manag Care 14 (2008) 234-254
106. Moreland L.W., Genovese M.C., Sato R., and Singh A. Effect of etanercept on fatigue in patients with recent or established rheumatoid arthritis. Arthritis Care Res 55 (2006) 287-293
107. Neill J., Belan I., and Ried K. Effectiveness of non-pharmacological interventions for fatigue in adults with multiple sclerosis, rheumatoid arthritis, or systemic lupus erythematosus: A systematic review. J Adv Nurs 56 (2006) 617-635
108. Evers A.W., Kraaimaat F.W., van Riel P.L., and de Jong A.J. Tailored cognitive-behavioral therapy in early rheumatoid arthritis for patients at risk: A randomized controlled trial. Pain 100 (2002) 141-153
109. National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases. Draft long-range plan for 2010-2014. 2009. http://www.niams.nih.gov/About_Us/Mission_and_Purpose/draft_long_range_p lan.asp Accessed December 22, 2009
110. Ader D.N. Developing the Patient-Reported Outcomes Measurement Information System (PROMIS). Med Care 45 Suppl 1 (2007) S1-S2